Cargando…

Nanozymes in Tumor Theranostics

Nanozymes, a new generation of enzyme mimics, have recently attracted great attention. Nanozymes could catalyze chemical reactions as biological enzymes under physiologically mild conditions with higher-efficiency catalytic activities. Moreover, nanozymes could overcome the shortcomings of natural e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Qiulian, Liu, Yanfang, Zhu, Haitao, Zhang, Lirong, Liao, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560966/ https://www.ncbi.nlm.nih.gov/pubmed/34737942 http://dx.doi.org/10.3389/fonc.2021.666017

Ejemplares similares

Nanozyme-based catalytic theranostics
por: Zhang, Yanan, et al.
Publicado: (2019)

Dual-targeting nanozyme for tumor activatable photo-chemodynamic theranostics
por: Chen, Chaoyi, et al.
Publicado: (2022)

Ferritins as natural and artificial nanozymes for theranostics
por: Jiang, Bing, et al.
Publicado: (2020)

Innate tumor-targeted nanozyme overcoming tumor hypoxia for cancer theranostic use
por: Veroniaina, Hanitrarimalala, et al.
Publicado: (2021)

Emerging two-dimensional material nanozymes for theranostic nanomedicine
por: You, Yanling, et al.
Publicado: (2021)

Deep Insight of Design, Mechanism, and Cancer Theranostic Strategy of Nanozymes
por: Yang, Lu, et al.
Publicado: (2023)

Nanozyme Hydrogels for Self-Augmented Sonodynamic/Photothermal Combination Therapy
por: Wang, Shuntao, et al.
Publicado: (2022)

Prostate Cancer Theranostics - An Overview
por: Abou, Diane, et al.
Publicado: (2020)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology
por: Rahmim, Arman, et al.
Publicado: (2022)

Clinical advancement of precision theranostics in prostate cancer
por: Tan, Yue, et al.
Publicado: (2023)

Editorial: Tumor microenvironment targeted nanomedicine: a feasible strategy for cancer imaging and theranostics
por: Xu, Yiming, et al.
Publicado: (2023)

SnFe(2)O(4) Nanozyme Based TME Improvement System for Anti-Cancer Combination Thermoradiotherapy
por: Zeng, Wen, et al.
Publicado: (2021)

Path to Clonal Theranostics in Luminal Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2022)

Nanozyme for tumor therapy: Surface modification matters
por: Tang, Guoheng, et al.
Publicado: (2021)

Fibroblast activation protein-based theranostics in pancreatic cancer
por: Cheng, Chien-shan, et al.
Publicado: (2022)

Editorial: Radiomics-based theranostics in cancer precision medicine
por: Ji, Jiansong, et al.
Publicado: (2023)

Mechanical Properties in the Glioma Microenvironment: Emerging Insights and Theranostic Opportunities
por: Bhargav, Adip G., et al.
Publicado: (2022)

A Sub-Nanostructural Transformable Nanozyme for Tumor Photocatalytic Therapy
por: Hu, Xi, et al.
Publicado: (2022)

Nanoprobes for Tumor Theranostics
por: Zhu, Jiaoyang, et al.
Publicado: (2022)

Somatostatin Receptor Avidity in Gastrointestinal Stromal Tumors: Theranostic Implications of Gallium-68 Scan and Eligibility for Peptide Receptor Radionuclide Therapy
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2017)

MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia
por: Alyami, Nouf M.
Publicado: (2021)

Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer
por: Li, Rou, et al.
Publicado: (2021)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Kirchner, Maximilian A., et al.
Publicado: (2021)

Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine
por: Hapuarachchige, Sudath, et al.
Publicado: (2020)

Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics
por: Jin, Jiefu, et al.
Publicado: (2020)

The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer
por: Poot, Alex J., et al.
Publicado: (2020)

Gold Nanoparticles in Cancer Theranostics
por: Gao, Qinyue, et al.
Publicado: (2021)

Circular RNAs as Potential Theranostics in the Cardiovascular System
por: Bei, Yihua, et al.
Publicado: (2018)

Applications of Functionalized Fullerenes in Tumor Theranostics
por: Chen, Zhiyun, et al.
Publicado: (2012)

Exploration of nanozymes in viral diagnosis and therapy
por: Lee, Jiyoung, et al.
Publicado: (2022)

Nanozymes as Enzyme Inhibitors
por: Huang, Yaling, et al.
Publicado: (2021)

Single-atom nanozymes
por: Huang, Liang, et al.
Publicado: (2019)

Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
por: Ng, Thomas S. C., et al.
Publicado: (2021)

PD-L1 siRNA Theranostics With a Dextran Nanoparticle Highlights the Importance of Nanoparticle Delivery for Effective Tumor PD-L1 Downregulation
por: Pacheco-Torres, Jesus, et al.
Publicado: (2021)

An In Situ Study on Nanozyme Performance to Optimize Nanozyme-Strip for Aβ Detection
por: Luo, Yaying, et al.
Publicado: (2023)

Tumor-derived covalent organic framework nanozymes for targeted chemo-photothermal combination therapy
por: Zhou, Shengnan, et al.
Publicado: (2023)

One-pot hydrothermal synthesis of metal-doped carbon dot nanozymes using protein cages as precursors
por: Shen, Yanfang, et al.
Publicado: (2023)

In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy
por: Fan, Kelong, et al.
Publicado: (2018)

Texture Analysis of DCE-MRI Intratumoral Subregions to Identify Benign and Malignant Breast Tumors
por: Zhang, Bin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g6b3n95fqrci9bu80e4lha2nj7